20462 ⎘
Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E, prostaglandin F
Hypotensive lipid-containing biodegradable intraocular implants and related methods
#902Method for Treating Primary and Secondary Forms of Glaucoma
#903Ophthalmic emulsions containing prostaglandins
#904COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
#905Prostaglandin compositions and methods for the treatment of vasospasm
#906Pharmaceutical composition for treating fecal incontinence and anal itch
#907Prostamides for the treatment of glaucoma and related diseases
#908Method of preparing a latanoprost opthalmic solution and the resulting solution
#909Preventive and/or remedy for lower urinary tract diseases containing EPagonist
#910Compositions and methods for reducing body fat
#911LYOPHILIZED PHARMACEUTICAL COMPOSITION
#912Use of a Cyclopentenone Prostaglandin for Delaying for the Onset and/or Preventing the Continuation of Labour
#913Method for the treatment of gastrointestinal disorders
#914Remedy for Cartilage-Related Diseases
#915Use of a Cyclopentenone Prostaglandin for Delaying the Onset and/or Preventing the Continuation of Labour
#916COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA
#917Drug delivery methods, structures, and compositions for nasolacrimal system
#918Osmotic drug delivery system
#919Opthalmic solutions
#920Ophthalmic oil-in-water type emulsion with stable positive zeta potential
#921Prostaglandin F2alpha derivative-containing product
#922Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
#923Nasolacrimal drainage system implants for drug therapy
#924THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
#925Therapeutic substituted cyclopentanones
#926Methods, compositions, and kits for the treatment of medical conditions
#927ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION
#928Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
#929Novel method and compositions for treatment of tinnitus
#930CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-THIOCARBAMOYLOXY AND 2-CARBAMOYLOXY COMPOUNDS AS THERAPEUTIC AGENTS
#931Stabilised prostaglandin composition
#932Method for treating chronic obstructive pulmonary disease
#933Method for treating primary and secondary forms of glaucoma
#934Delayed release pharmaceutical oral dosage form and method of making same
#935Soft-gelatin capsule formulation
#936Methods for treating cutaneous lupus using aminoisoindoline compounds
#937Blood flow promoters for cauda equina tissues
#938THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS
#939Therapeutic methods using prostaglandin EPagonist components
#940Nitrosated and nitrosylated prostaglandins, compositions and methods of use
#941Methods, compositions, and kits for the treatment of ophthalmic disorders
#942Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives
#943Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
#944Vaginal tablets comprising misoprostol and methods of making and using the same
#945Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure
#946Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
#947Injectable Osteogenic Formula and Method of Using Same
#948Method for treating peripheral vascular diseases
#949Oil-in-water method for making polymeric implants containing a hypotensive lipid
#950Enteric coated composition comprising prostaglandin analogs as chloride channel opener
#951Compositions and methods of therapy
#952Methods for control of tumors and chronic infections by modulating immunologically informed carriers homing to tolerogenic organs or tissues
#953Enhanced bimatoprost ophthalmic solution
#954Method for treating ocular hypertension and glaucoma
#955Product containing prostaglandin
#956External preparation for improving coital function
#957Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
#958Methods for identifying IκB Kinase (IKK) inhibitors
#959Remedies for allergic diseases
#960Topical drug delivery system
#961Agentfor reducing side effects of diclofenac
#962Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
#963Novel inhibitors of ubiquitin isopeptidases
#964Inhalable formulations for treating pulmonary hypertension and methods of using same
#965Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
#966Intravenous composition, process for producing the same and preparation thereof
#967Transparent eye drops containing latanoprost
#968Medicine of post-traumatic stress disorder
#969Control of a biological function
#970Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
#971Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
#972Method for providing a cathartic effect
#973Prostaglandin compounds for the treatment of obesity
#974Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
#975Hypotensive lipid-containing biodegradable intraocular implants and related methods
#976Drug delivery via punctal plug
#977Stable eye drops containing latanoprost as the active ingredient
#978Ophthalmic solution
#979Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#980Anti-constipation composition
#981Treatment of inflammatory bowel disease
#982Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
#983Combination therapy for glaucoma treatment
#984Pharmaceuticals for xerosis
#985Topical stabilized prostaglandin E compound dosage forms
#986Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
#987Use of treprostinil to improve kidney functions
#988Treatment of inflammatory bowel disease
#989Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
#990Compound for treatment of external secretion disorders
#991Delivery of biologically active agents
#992As-needed administration of an androgenic agent to enhance female desire and responsiveness
#993Penis enlargement
#994Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
#995Remedies for glaucoma comprising bunazosin and prostaglandins
#996Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient
#997Method for treating ocular hypertension and glaucoma
#998Prostaglandin compositions and methods for the treatment of vasospasm
#999Antipruritic agent
#1000Preservative free pharmaceutical compositions for ophthalmic administration
#1001Processes for preparing cyclopenta[b]naphthalenol derivatives and intermediates thereof
#1002Method for treating vascular disease by administering a liposomal prostaglandin composition
#1003Treatment method for primary premature ejaculation
#1004Compositions and methods for treatment of premature ejaculation